MS
70
6
PNR
60
3
ROK
48
2
WMB
62
2
MAT
43
2
TEL
60
2
GT
47
4
URI
39
3
LNC
29
4
BK
61
3
BLK
54
4
GS
58
5
AME
50
3
EIX
62
3
HPE
38
2
CVX
17
3
CAH
47
2
DFS
70
5
SPG
50
4
NOV
50
3
MS
70
6
PNR
60
3
ROK
48
2
WMB
62
2
MAT
43
2
TEL
60
2
GT
47
4
URI
39
3
LNC
29
4
BK
61
3
BLK
54
4
GS
58
5
AME
50
3
EIX
62
3
HPE
38
2
CVX
17
3
CAH
47
2
DFS
70
5
SPG
50
4
NOV
50
3
Financhill
Back

Vasta Platform 10K Form

Buy
58

VSTA
Vasta Platform

Last Price:
$2.23
Seasonality Move:
3.77%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive VSTA News And Ratings

See the #1 stock for the next 7 days that we like better than VSTA

VSTA Financial Statistics

Sales & Book Value

Annual Sales: $297.8M
Cash Flow: $8.2M
Price / Cash Flow: 14.97
Annual Sales: $10.06
Price / Book: 0.23

Profitability

EPS (TTM): -0.12580
Net Income (TTM): $-10M
Gross Margin: $183.4M
Return on Equity: -1.15%
Return on Assets: -0.7%

Vasta Platform Earnings Forecast

Key Vasta Platform Financial Ratios

  • The Gross Profit Margin over the past 5 years for VSTA is 61.59%.
  • The Selling, General & Administrative Expenses for VSTA have been equal to 47.88% of Gross Profit Margin.
  • The Research & Development expenses have been 6.57% of Revenue.
  • The Interest Expense is -348.46% of Operating Income.
  • The Net Earning history of VSTA is -5.64% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

Vasta Platform Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Diversified Consumer Services
Sector: Consumer Discretionary
Current Symbol: VSTA
CUSIP: G9440A
Website: vastaedu.com.br

Debt

Debt-to-Equity Ratio: 0.24
Current Ratio: 1.21
Quick Ratio: 0.82

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 6.74

VSTA Technical Analysis vs Fundamental Analysis

Buy
58
Vasta Platform (VSTA) is a Buy

Is Vasta Platform a Buy or a Sell?

  • Vasta Platform stock is rated a Buy
    The current Vasta Platform [VSTA] share price is $2.29. The Score for VSTA is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.